Literature DB >> 8105956

Peritoneal laceration: a rare cause of scrotal edema in a 2-year-old boy.

C H Schröder1, P Rieu, M C de Jong.   

Abstract

Genital swelling is a common complication in continuous ambulatory peritoneal dialysis (CAPD) patients. It is generally caused by patent processus vaginalis. Sometimes peritoneal damage leads to edema shortly after the insertion of a CAPD catheter. The present paper describes peritoneal damage after one year of dialysis using a single (Toronto Western Hospital II pediatric) catheter due to erosion. A 2-year-old boy was admitted to the hospital with severe scrotal edema. Exploration of both inguinal regions showed no patent processus vaginalis. At laparotomy a 1 x 1-cm perforation was found at the back of the bladder, where the tip of the catheter was located. After closing the perforation and repositioning the CAPD catheter, the symptoms disappeared within 2 days; CAPD treatment was not interrupted. Peritoneal laceration is described as a cause of bowel perforation in CAPD patients. This case history shows that it may be the cause of genital swelling as well. The presence of the disks of the catheter may have contributed to this unknown complication.

Entities:  

Mesh:

Year:  1993        PMID: 8105956

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  3 in total

1.  Guidelines for laparoscopic peritoneal dialysis access surgery.

Authors:  Stephen Haggerty; Scott Roth; Danielle Walsh; Dimitrios Stefanidis; Raymond Price; Robert D Fanelli; Todd Penner; William Richardson
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

Review 2.  Management of Peritoneal Dialysis Catheters That Erode Into Bowel: Two Pediatric Case Reports and a Review of the Literature.

Authors:  Troy A Markel; Karen W West
Journal:  Perit Dial Int       Date:  2016 11-12       Impact factor: 1.756

3.  Laparoscopy to evaluate scrotal edema during peritoneal dialysis.

Authors:  Stephen P Haggerty; Juaquito M Jorge
Journal:  JSLS       Date:  2013 Jul-Sep       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.